0001062993-21-001199.txt : 20210210
0001062993-21-001199.hdr.sgml : 20210210
20210210191822
ACCESSION NUMBER: 0001062993-21-001199
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210208
FILED AS OF DATE: 20210210
DATE AS OF CHANGE: 20210210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Petrova Penka
CENTRAL INDEX KEY: 0001838044
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36596
FILM NUMBER: 21615827
MAIL ADDRESS:
STREET 1: C/O TRILLIUM THERAPEUTICS INC.
STREET 2: 2488 DUNWIN DRIVE
CITY: MISSISSAUGA
STATE: A6
ZIP: L5L 1J9
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trillium Therapeutics Inc.
CENTRAL INDEX KEY: 0001616212
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2488 DUNWIN DRIVE
CITY: MISSISSAUGA
STATE: A6
ZIP: L5L 1J9
BUSINESS PHONE: (416) 595-0627
MAIL ADDRESS:
STREET 1: 2488 DUNWIN DRIVE
CITY: MISSISSAUGA
STATE: A6
ZIP: L5L 1J9
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2021-02-08
0001616212
Trillium Therapeutics Inc.
TRIL
0001838044
Petrova Penka
C/O TRILLIUM THERAPEUTICS INC.
2488 DUNWIN DRIVE
MISSISSAUGA
A6
L5L 1J9
ONTARIO, CANADA
0
1
0
0
Chief Development Officer
Common Shares
2021-02-08
4
M
0
2708
0.2977
A
2708
D
Common Shares
2021-02-08
4
M
0
2604
3.3137
A
5312
D
Common Shares
2021-02-08
4
S
0
5312
12.65
D
0
D
Common Shares
2021-02-09
4
M
0
508
9.6213
A
508
D
Common Shares
2021-02-09
4
S
0
508
14.174
D
0
D
Stock Option (Right to Buy)
0.2977
2021-02-08
4
M
0
2708
0
D
2029-11-07
Common Shares
2708
89376
D
Stock Option (Right to Buy)
3.3137
2021-02-08
4
M
0
2604
0
D
2028-11-08
Common Shares
2604
54688
D
Stock Option (Right to Buy)
9.6213
2021-02-09
4
M
0
508
0
D
2027-11-09
Common Shares
508
4574
D
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
The exercise price of these options is $0.38 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7834 USD.
The exercise price of these options is $4.23 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7834 USD.
The exercise price of these options is $12.22 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7873 USD.
25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months.
/s/ James Parsons, Attorney-in-Fact
2021-02-10